Summary statement: utility of molecular marker testing in thyroid cancer.
Summary statement: utility of molecular marker testing in thyroid cancer.
复制标题
摘要：分子标记物检测在甲状腺癌中的实用性。
DOI：
10.1016/j.surg.2010.09.023
复制
发表时间：
2010
期刊：
影响因子：
3.8
通讯作者：
Nikiforov,YuriE
中科院分区：
文献类型：
--
作者：
Yip,Linwah;Kebebew,Electron;Milas,Mira;Carty,SallyE;Fahey3rd,ThomasJ;Parangi,Sareh;Zeiger,MarthaA;Nikiforov,YuriE
使用分子标记进行甲状腺癌诊断、预后和监测一直是一个令人兴奋的研究和变革领域。最近对有前景的新标志物的研究重点很可能会提高细针抽吸活检（FNAB）在预测恶性肿瘤方面的诊断效用，并提供更准确的术前和术后预后信息。美国内分泌外科医生协会 2010 年年会举办了一场专门讨论甲状腺癌分子标志物检测及其潜在临床应用的研讨会。
The use of molecular markers for thyroid cancer diagnosis, prognosis, and surveillance have been an exciting area of study and change. Recent investigative focus on promising new markers will very likely lead to improvements in the diagnostic utility of fine needle aspiration biopsy (FNAB) in predicting malignancy, as well as provide more accurate prognostic information pre- and postoperatively. The 2010 Annual Meeting of the American Association for Endocrine Surgeons featured a symposium dedicated to molecular marker testing in thyroid cancer and its potential clinical applicability.